| Name | Title | Contact Details |
|---|
I Am Boundless provides community based supports and services for individuals with intellectual and behavioral developmental disabilities.
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
Tethys Bioscience is a personalized predictive medicine company developing novel tests which address the growing global healthcare challenge of chronic diseases such as diabetes.
Heal brings a licensed, background-checked pediatrician or family doctor to you, on-demand, on your schedule, for $99 or in-network with your insurance. Great doctors are available in Los Angeles, Orange County, Silicon Valley, San Diego and San Francisco from 8am to 8pm, seven days a week.
Excredsys is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.